CNSP — CNS Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for CNS Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14 | -15.3 | -18.9 | -14.9 | -15.9 |
| Depreciation | |||||
| Non-Cash Items | 1.72 | 1.54 | 1.01 | 1.44 | 0.19 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.24 | 3.16 | 3.7 | -3.69 | 1.85 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -13.5 | -10.6 | -14.1 | -17.1 | -13.8 |
| Capital Expenditures | -0.006 | -0.004 | -0.004 | -0.004 | -0.018 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.006 | -0.004 | -0.004 | -0.004 | -0.018 |
| Financing Cash Flow Items | 0 | — | — | -0.067 | 0.816 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.51 | 15.6 | 4.64 | 23 | 14.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.03 | 5.05 | -9.51 | 5.91 | 0.74 |